Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade)

Jan 6, 2025 · Summary: Amgen Is Back To A Buy Amgen is a proven dividend grower and makes up 1% of my portfolio. The company's recent and upcoming biosimilar drug launches should …

CouponFollow Extension

1%
OFF

Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade)

2 weeks from now

Jan 6, 2025 · Summary: Amgen Is Back To A Buy Amgen is a proven dividend grower and makes up 1% of my portfolio. The company's recent and upcoming biosimilar drug launches should …

seekingalpha.com

$324
OFF

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

2 days ago · In other recent news, Amgen has been the subject of various analyst updates and developments. RBC (TSX: RY) Capital revised its price target for Amgen's stock from $324 to …

investing.com

$383.00
OFF

Amgen’s Growth Potential Affirmed: Buy Rating With Increased …

2 weeks from now

Oct 21, 2024 · TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $383.00.. Yaron Werber has given his Buy …

businessinsider.com

$370.00
OFF

Goldman Sachs Backs Amgen Shares With Buy Rating, Emphasizing …

2 weeks from now

Jan 8, 2025 · On Wednesday, Goldman Sachs reaffirmed its Buy rating and $370.00 price target for Amgen (NASDAQ: AMGN) shares. The firm's analyst, Salveen Richter, provided insights …

investing.com

75%
OFF

Is Amgen Stock A Buy Now? - The Motley Fool

2 weeks from now

Oct 20, 2022 · Shares of Amgen (AMGN-0.75%) have been rising of late after a recent analyst upgrade generated some bullishness around the biotech company. Year to date, the stock is …

fool.com

5%
OFF

Amgen Stock Surges To 10-Month High, Up 5% On An …

2 weeks from now

Oct 11, 2023 · The upgrade comes ahead of Amgen's third-quarter earnings report, slated for Oct. 31. Wall Street expects Amgen to earn an adjusted $4.67 per share on $6.93 billion in sales.

investors.com

04%
OFF

Amgen's Beating The Market -- Here's Why It's A Buy Now

2 weeks from now

Jul 1, 2022 · Amgen (AMGN 3.04%) is the world's largest biotechnology company by revenue, focusing on using living cells to create a robust product portfolio of biologic medicines to treat …

fool.com

49%
OFF

Is Amgen Stock Still A Buy After An Unexpected Reveal Of Data?

2 weeks from now

Nov 29, 2024 · Shares of Amgen (AMGN 0.49%) are down by 6% in the last 30 days as I write this -- a larger-than-normal amount for a large pharma company's stock to fall, especially …

fool.com

05%
OFF

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

2 weeks from now

Nov 16, 2024 · While Amgen's (AMGN 0.05%) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

fool.com

FAQs about Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade) Coupon?

Should you buy Amgen (AMGN)?

27 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Amgen in the last twelve months. There are currently 2 sell ratings, 12 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" AMGN shares. ...

Is Amgen (AMGN) a good stock to buy in October 2023?

Amgen Inc.'s AMGN, -0.11% pipeline of cancer, obesity and cardiovascular drugs is poised to deliver good news for the stock, analysts say, despite the company's recent setback with cancer drug Lumakras. There are 20 stocks on my high yield watchlist for October 2023. ...

Is Amgen (Amgen) a good stock to buy?

Shares of Amgen currently trade at 21 times trailing earnings. That's in line with the average healthcare stock, which trades at 20 times profits. And compared to other top drugmakers, Amgen's valuation looks even more reasonable: ...

What is the price target for Amgen (AMGN)?

The highest price target for AMGN is $405.00, while the lowest price target for AMGN is $195.00. The average price target represents a forecasted upside of 8.70% from the current price of $288.87. Enter your email address to receive the latest news and analysts' ratings for Amgen and its competitors. ...

Why has Yaron Werber rated Amgen (Amgen) a buy?

Yaron Werber has given his Buy rating due to a combination of factors affecting Amgen’s stock. Primarily, the increase in the price target to $383 reflects a positive outlook, driven by a slight adjustment in the valuation multiple applied to future earnings. ...

What happened to Amgen stock in 2024?

The Amgen stock price suffered a harsh reversal in the fourth quarter of 2024 as its weight loss drug failed to excite. After peaking at $341 in July, the stock plunged by over 25% to the current $260... Will Dow Jones index 2024 losers become 2025 gainers? ...